215 related articles for article (PubMed ID: 16247417)
1. Daclizumab for children with corticosteroid refractory graft-versus-host disease.
Teachey DT; Bickert B; Bunin N
Bone Marrow Transplant; 2006 Jan; 37(1):95-9. PubMed ID: 16247417
[TBL] [Abstract][Full Text] [Related]
2. Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.
Wolff D; Wilhelm S; Hahn J; Gentilini C; Hilgendorf I; Steiner B; Kahl C; Junghanss C; Hartung G; Casper J; Uharek L; Holler E; Freund M
Bone Marrow Transplant; 2006 Sep; 38(6):445-51. PubMed ID: 16951692
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
Perales MA; Ishill N; Lomazow WA; Weinstock DM; Papadopoulos EB; Dastigir H; Chiu M; Boulad F; Castro-Malaspina HR; Heller G; Jakubowski AA; O'Reilly RJ; Small TN; Young JW; Kernan NA
Bone Marrow Transplant; 2007 Sep; 40(5):481-6. PubMed ID: 17618322
[TBL] [Abstract][Full Text] [Related]
4. Improved survival and preserved antiviral responses after combination therapy with daclizumab and infliximab in steroid-refractory graft-versus-host disease.
Rao K; Rao A; Karlsson H; Jagani M; Veys P; Amrolia PJ
J Pediatr Hematol Oncol; 2009 Jun; 31(6):456-61. PubMed ID: 19648797
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
[TBL] [Abstract][Full Text] [Related]
6. Daclizumab therapy for children with corticosteroid-resistant acute graft-vs.-host disease.
Schechter T; Afzal S; Finkelstein Y; Koren G; Doyle J; Dupuis LL
Pediatr Transplant; 2009 May; 13(3):332-7. PubMed ID: 18482218
[TBL] [Abstract][Full Text] [Related]
7. Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept.
Wolff D; Roessler V; Steiner B; Wilhelm S; Weirich V; Brenmoehl J; Leithaeuser M; Hofmeister N; Junghanss C; Casper J; Hartung G; Holler E; Freund M
Bone Marrow Transplant; 2005 May; 35(10):1003-10. PubMed ID: 15806135
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of children treated with daclizumab for steroid-refractory gastrointestinal GvHD in a prospective study.
Hamidieh AA; Hadjibabaie M; Ghehi MT; Jalili M; Hosseini A; Pasha F; Behfar M; Ghavamzadeh A
Pediatr Transplant; 2012 Sep; 16(6):664-9. PubMed ID: 22738324
[TBL] [Abstract][Full Text] [Related]
9. Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease.
Bordigoni P; Dimicoli S; Clement L; Baumann C; Salmon A; Witz F; Feugier P
Br J Haematol; 2006 Nov; 135(3):382-5. PubMed ID: 16984386
[TBL] [Abstract][Full Text] [Related]
10. Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience.
Miano M; Cuzzubbo D; Terranova P; Giardino S; Lanino E; Morreale G; Castagnola E; Dini G; Faraci M
Bone Marrow Transplant; 2009 Mar; 43(5):423-7. PubMed ID: 18850021
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
[TBL] [Abstract][Full Text] [Related]
12. Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapy.
Cuthbert RJ; Phillips GL; Barnett MJ; Nantel SH; Reece DE; Shepherd JD; Klingemann HG
Bone Marrow Transplant; 1992 Nov; 10(5):451-5. PubMed ID: 1464009
[TBL] [Abstract][Full Text] [Related]
13. Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
Rodriguez V; Anderson PM; Trotz BA; Arndt CA; Allen JA; Khan SP
Pediatr Blood Cancer; 2007 Aug; 49(2):212-5. PubMed ID: 16261610
[TBL] [Abstract][Full Text] [Related]
14. Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease.
Mayer J; Krejcí M; Doubek M; Pospísil Z; Brychtová Y; Tomíska M; Rácil Z
Bone Marrow Transplant; 2005 Apr; 35(7):699-705. PubMed ID: 15696180
[TBL] [Abstract][Full Text] [Related]
15. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
[TBL] [Abstract][Full Text] [Related]
16. Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients.
Racadot E; Milpied N; Bordigoni P; Cahn JY; Plouvier E; Lioure B; Lutz P; Wijdenes J; Herve P
Bone Marrow Transplant; 1995 May; 15(5):669-77. PubMed ID: 7670394
[TBL] [Abstract][Full Text] [Related]
17. Infliximab treatment for steroid-refractory acute graft-versus-host disease.
Patriarca F; Sperotto A; Damiani D; Morreale G; Bonifazi F; Olivieri A; Ciceri F; Milone G; Cesaro S; Bandini G; Dini G; Corradini P; Fanin R
Haematologica; 2004 Nov; 89(11):1352-9. PubMed ID: 15531458
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide.
Mayer J; Krejci M; Pospisil Z; Doubek M; Janikova A; Zackova D; Racil Z; Smardova L; Navratil M; Kamelander J
Exp Hematol; 2009 Jun; 37(6):767-73. PubMed ID: 19463776
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
[TBL] [Abstract][Full Text] [Related]
20. Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease.
Iyer RV; Hahn T; Roy HN; Battiwalla M; Cooper M; Anderson B; Paplham P; Brown K; Bambach B; Segal BH; McCarthy PL
Biol Blood Marrow Transplant; 2005 Aug; 11(8):587-92. PubMed ID: 16041308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
